Australia’s health-related cannabis industry could surpass 15,000 patient application approvals by the finish of this year, with sector revenues totaling roughly 36 million Australian dollars ($25 million), according to an analyst’s forecast.
Though each totals may well look low by North American requirements, they represent “a decent start” for the country’s emerging health-related cannabis sector, mentioned Matthijs Smith, senior analyst at Canaccord Genuity Group in Australia.
If month-to-month approvals continue to match the February pace, a total of 11,600 patient approvals will have been granted by the finish of 2019.
“We are expecting development in these numbers, so it is pretty attainable that 15,000-plus applications may well have been authorized by the finish of the year,” he mentioned.
Smith mentioned barriers to accessing cannabis for health-related purposes are larger in Australia compared to markets such as Canada.
“We are nonetheless attempting to get a really feel for how huge and accessible is the relevant patient pool,” Smith mentioned.
“Our back-of-the-envelope calculations recommend that up to 500,000 Australians may well advantage from utilizing cannabis items for health-related purposes.”
A year ago, federal and state governments sought to reduce red tape to increase access to health-related cannabis by introducing a single application course of action on the Therapeutic Goods Administration’s internet site.
Even though important barriers stay, early information shows access has observed some improvement.
Ahead of the adjustments, only 73 requests to treat individuals with health-related cannabis had been authorized.
Considering that the red tape was reduce in March 2018, roughly three,800 applications have been granted.
Month-to-month approvals have grown steadily. Fifty-4 applications had been authorized in March 2018, even though 739 had been authorized in February 2019.
“There has been a concerted work to increase and streamline the course of action, which has resulted in a important uptick in individuals more than the final six-eight months,” Smith mentioned.
Matt Lamers can be reached at [email protected]
To sign up for our weekly international cannabis small business newsletter, click right here.